Merial, Inc.
Adjuvanted rabies vaccine with improved viscosity profile
The present invention relates to adjuvanted recombinant anti-rabies vaccines and the oral administration of such vaccines to raccoons and other wildlife. Advantageously, the anti-rabies vaccine may comprise a recombinant vaccinia virus containing a rabies glycoprotein gene. The invention encompasses methods of vaccinating raccoons and other wildlife by administration of an anti-rabies vaccines which may comprise a recombinant vaccinia virus containing a rabies glycoprotein gene, in combination with an adjuvant which increases both vaccine viscosity and efficacy. The invention provides effective oral recombinant vaccines used in oral rabies vaccination (ORV) programs for wildlife, effective at protecting raccoons, gray foxes, coyotes, and other animals.
MERIAL, INC. The United States of America As Represented By The Secretary of Agriculture
A A C C C C A A A C A A A C
A61K A61P C07K C12N C12N C12N A61K A61K A61K C12N A61K A61P A61K C12N
inventional inventional additional additional additional additional additional additional inventional additional inventional inventional additional additional
Jerome Cornelius Joanne L. Lowell Allen Tricia Lynn
Hurley Maki Miller Fry